|
LOC284023 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.950790E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.214800E-04 |
| Normal-vs-Stage2 |
8.404200E-01 |
| Normal-vs-Stage3 |
5.041600E-04 |
| Normal-vs-Stage4 |
1.721550E-03 |
| Stage1-vs-Stage2 |
4.157500E-02 |
| Stage1-vs-Stage3 |
4.017000E-01 |
| Stage1-vs-Stage4 |
5.047400E-01 |
| Stage2-vs-Stage3 |
1.324190E-02 |
| Stage2-vs-Stage4 |
1.504300E-02 |
| Stage3-vs-Stage4 |
9.202400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.47870000000106E-05 |
| Normal-vs-AfricanAmerican |
2.424200E-01 |
| Normal-vs-Asian |
3.648400E-04 |
| Caucasian-vs-AfricanAmerican |
5.904000E-01 |
| Caucasian-vs-Asian |
3.319400E-01 |
| AfricanAmerican-vs-Asian |
2.745400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.368620E-04 |
| Normal-vs-Female |
1.284740E-03 |
| Male-vs-Female |
1.630580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.351700E-04 |
| Normal-vs-Age(41-60Yrs) |
7.363500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.642300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.406420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.243000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.351200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.526400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.074400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.005200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.474800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.372600E-01 |
| Classical-VS-Follicular |
3.30160000450164E-08 |
| Classical-VS-Other |
8.018400E-01 |
| Classical-VS-Normal |
5.03969999954279E-07 |
| Tall-VS-Follicular |
1.363820E-04 |
| Tall-VS-Other |
7.917400E-01 |
| Tall-VS-Normal |
4.981000E-04 |
| Follicular-VS-Other |
2.017800E-01 |
| Follicular-VS-Normal |
3.777400E-01 |
| Other-VS-Normal |
2.702000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.660000E-02 |
| Normal-vs-N1 |
1.217730E-02 |
| N0-vs-N1 |
1.594580E-01 |
|
|
